The complex molybdohemoflavoprotein, NADH:nitrate reductase (NR; E.C. 1.6.6.1). catalyzes the reduction of nitrate to nitrite using NADH as the physiological electron donor, a reaction that represents the regulated and rate-limiting step in the pathway of nitrogen assimilation in eukaryotes. The dimeric enzyme exhibits a tripartite structure with individual subunits comprising functional domains that contain Mo-pterin, cytochrome b557 and FAD prosthetic groups in a 1:1:1 stoichiometry with FAD as the site of electron ingress and Mo-pterin as the egress site for the conversion of nitrate to nitrite. The overall goal of the proposed research is to identify and characterize molecular and physical determinants that regulate the catalytic efficiency of NR, which represents an excellent model for investigating electron transfer reactions in complex, multi-center proteins containing diverse prosthetic groups and which shares a number of common structural and mechanistic features with a variety of other flavin-, heme- and Mo-containing proteins including cytochrome b5 reductase, ferredoxin:NADP+ reductase, cytochrome b5 and sulfite oxidase. We pioneered a reductionist approach and have successfully developed heterologous expression systems for the individual, functional Mo-pterin, heme and FAD domains as well as the Mo-pterin/heme and heme/FAD fusion domain, to probe factors influencing cofactor redox potentials and the regulation of FAD-heme and heme-Mo-pterin energy transduction. The proposed research will focus on integrating site-directed mutagenesis and extensive spectroscopic, thermodynamic and structural analyses to define the roles of selected amino acid residues in the various NR domains in controlling cofactor redox potentials together with examining the effects of relative cofactor redox potential modulation on the efficiency of energy transduction within NR. Specific motifs including the RXY-T sXXsN and """"""""CGXXXM"""""""" sequences involved in FAD- and NADH-binding, the role of the Mo-heme """"""""linker"""""""" region in controlling the heme potential and the role of the """"""""CAG"""""""" Mo-pterin signature will be examined. These studies will enhance our understanding of important structure-function relationships in NR and other related metalloflavoproteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM032696-19
Application #
6942343
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Ikeda, Richard A
Project Start
1984-09-27
Project End
2008-08-31
Budget Start
2005-09-01
Budget End
2008-08-31
Support Year
19
Fiscal Year
2005
Total Cost
$212,570
Indirect Cost
Name
University of South Florida
Department
Biochemistry
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Percy, M J; Crowley, L J; Boudreaux, J et al. (2006) Expression of a novel P275L variant of NADH:cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide binding. Arch Biochem Biophys 447:59-67
Percy, M J; Crowley, L J; Roper, D et al. (2006) Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant. Blood Cells Mol Dis 36:81-90
Roma, Glenn W; Crowley, Louis J; Barber, Michael J (2006) Expression and characterization of a functional canine variant of cytochrome b5 reductase. Arch Biochem Biophys 452:69-82
Percy, M J; Crowley, L J; Davis, C A et al. (2005) Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase. Br J Haematol 129:847-53
Marohnic, Christopher C; Crowley, Louis J; Davis, C Ainsley et al. (2005) Cytochrome b5 reductase: role of the si-face residues, proline 92 and tyrosine 93, in structure and catalysis. Biochemistry 44:2449-61
Roma, Glenn W; Crowley, Louis J; Davis, C Ainsley et al. (2005) Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase. Biochemistry 44:13467-76
Davis, C Ainsley; Barber, Michael J (2004) Cytochrome b5 oxidoreductase: expression and characterization of the original familial ideopathic methemoglobinemia mutations E255- and G291D. Arch Biochem Biophys 425:123-32
Davis, C Ainsley; Crowley, Louis J; Barber, Michael J (2004) Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*. Arch Biochem Biophys 431:233-44
Pollock, Veronica V; Conover, Richard C; Johnson, Michael K et al. (2003) Biotin sulfoxide reductase: Tryptophan 90 is required for efficient substrate utilization. Arch Biochem Biophys 409:315-26
Bewley, Maria C; Davis, C Ainsley; Marohnic, Christopher C et al. (2003) The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site. Biochemistry 42:13145-51

Showing the most recent 10 out of 63 publications